Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 2
2008 1
2009 2
2010 2
2011 2
2014 2
2015 4
2016 2
2017 5
2018 8
2019 5
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean kuang qing lin (1 results)?
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
Peng Z, Chen S, Wei M, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Chen M, Qian G, Kuang M. Peng Z, et al. Radiology. 2018 May;287(2):705-714. doi: 10.1148/radiol.2018171541. Epub 2018 Feb 1. Radiology. 2018. PMID: 29390197 Clinical Trial.
Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.
Shen S, Peng H, Wang Y, Xu M, Lin M, Xie X, Peng B, Kuang M. Shen S, et al. BMC Cancer. 2018 Jan 31;18(1):117. doi: 10.1186/s12885-018-4011-8. BMC Cancer. 2018. PMID: 29386009 Free PMC article.
Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study.
Cui Y, Fang W, Li C, Tang K, Zhang J, Lei Y, He W, Peng S, Kuang M, Zhang H, Chen L, Xu D, Tang C, Zhang W, Zhu Y, Jiang W, Jiang N, Sun Y, Chen Y, Wang H, Lai Y, Li S, He Q, Zhou J, Zhang Y, Lin M, Chen H, Zhou C, Wang C, Wang J, Zou X, Wang L, Ke Z. Cui Y, et al. Clin Cancer Res. 2019 Mar 1;25(5):1546-1556. doi: 10.1158/1078-0432.CCR-18-2545. Epub 2018 Nov 2. Clin Cancer Res. 2019. PMID: 30389658 Free article. Clinical Trial.
Non-enhanced Pattern on Contrast-Enhanced Ultrasound in the Local Efficacy Assessment of Irreversible Electroporation Ablation of Pancreatic Adenocarcinoma.
Lin M, Xie X, Xu M, Feng S, Tian W, Zhuang B, Su L, Ye J, Lin J, Liang P, Yu J, Kuang M. Lin M, et al. Ultrasound Med Biol. 2018 Sep;44(9):1986-1995. doi: 10.1016/j.ultrasmedbio.2018.05.018. Epub 2018 Jul 25. Ultrasound Med Biol. 2018. PMID: 30055820
Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
Chen S, Peng Z, Xiao H, Lin M, Chen Z, Jiang C, Hu W, Xie X, Liu L, Peng B, Kuang M. Chen S, et al. Int J Hyperthermia. 2018 Nov;34(7):1029-1037. doi: 10.1080/02656736.2017.1387941. Epub 2017 Nov 16. Int J Hyperthermia. 2018. PMID: 28974113
Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
Chen S, Peng Z, Lin M, Chen Z, Hu W, Xie X, Liu L, Qian G, Peng B, Li B, Kuang M. Chen S, et al. Eur Radiol. 2018 Sep;28(9):3651-3660. doi: 10.1007/s00330-018-5371-9. Epub 2018 Mar 29. Eur Radiol. 2018. PMID: 29600474 Clinical Trial.
Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M. Peng Z, et al. Eur Radiol. 2018 Aug;28(8):3522-3531. doi: 10.1007/s00330-017-5166-4. Epub 2018 Mar 13. Eur Radiol. 2018. PMID: 29536241
Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
Chen LD, Ruan SM, Lin Y, Liang JY, Shen SL, Hu HT, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W. Chen LD, et al. Eur Radiol. 2019 Aug;29(8):4249-4257. doi: 10.1007/s00330-018-5927-8. Epub 2018 Dec 19. Eur Radiol. 2019. PMID: 30569182
Salvage resection for recurrent or metastatic hepatocellular carcinoma after percutaneous ablation therapy.
Hu W, Peng Z, Li D, Shen S, Li J, Ruan S, Zhang M, Liu B, Lin M, Li S, He Q, Peng B, Xie X, Lu M, Kuang M. Hu W, et al. Int J Surg. 2016 Dec;36(Pt A):68-73. doi: 10.1016/j.ijsu.2016.07.066. Epub 2016 Jul 29. Int J Surg. 2016. PMID: 27477949 Free article.
Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
Liu D, Liu M, Su L, Wang Y, Zhang X, Long H, Kuang M, Xie X, Lin M. Liu D, et al. J Vasc Interv Radiol. 2019 Dec;30(12):1879-1886. doi: 10.1016/j.jvir.2019.07.029. Epub 2019 Oct 24. J Vasc Interv Radiol. 2019. PMID: 31669087
34 results
Jump to page
Feedback